Targeting epigenetic disruptions in cancer holds promise. Our latest paper in @LeukemiaJnl reveals a novel viral mimicry-interferon mechanism enhancing HDAC3 inhibition in GNAS knockout lymphoma. Proud to lead this challenging project with an amazing team!
https://t.co/aIhVPK2DWy
We are looking for a talented postdoctoral bioinformatician @TheDawsonLab to work with us on single cell multiomics incorporating lineage tracing and spatial technologies- we specifically want someone curious, fearless with a licence to innovate!! https://t.co/gBpTDjb3kI
Today in @Nature we share our back-to-back stories with @nzhenguw revealing chemical-genetic convergence between a molecular glue & E3 ligase cancer mutations. 1/6
UHN is proud to be ranked #1 on the list of Canada’s Top 40 Research Hospitals from @R_Infosource for the 14th year in a row!
Thanks to our incredible research community for their continued dedication to #HealthDiscovery, #care & #education!
🔗https://t.co/2RMZhfFife
It takes two to think. Science is a contact sport and one of the reasons why trends in remote work risk scientific progress. Get together - inspire each other.
I know I must read this masterpiece when I see @MAF_Dawson!
Very happy to see a comprehensive review on the hallmarks of cancer - an epigenetic perspective. Thank you to all the authors.
🥁Out today in the October issue of @CD_AACR: ⭐️The Epigenetic Hallmarks of Cancer⭐️ - by @ManelEsteller, @MAF_Dawson, @CKadoch, Feyruz Rassool, Peter Jones, and Steve Baylin https://t.co/Yv48EXBxz5
Transcriptional/epigenetic chemical inducers of proximity (TCIPs) are an innovative new class of therapeutics that are set to impact lymphoma and other malignancies. Here @RomanSarott, @saigourisankar describe a CDK9 "catch and release" MOA for a new TCIP.
https://t.co/R6D1PU50KQ
As #BloodCancerAwarenessMonth wraps up, we want to congratulate @PMResearch_UHN’s Dr. Robert Kridel @rkridel for publishing three new studies on #lymphoma.
Learn about his team’s dedication to advancing cancer research:
📽️https://t.co/QJmz95lu3o
Excited to kick off the fight against #lymphoma with a first score! Honored to work with Dr. Kridel and a great team for these achievements. As Michael Jordan said, 'Talent wins games, but teamwork and intelligence wins championships.' Here’s to more victories in cancer research!
As #BloodCancerAwarenessMonth wraps up, we want to congratulate @PMResearch_UHN’s Dr. Robert Kridel @rkridel for publishing three new studies on #lymphoma.
Read about his team’s dedication to advancing cancer research using genetic analysis.
🔗https://t.co/tCui8kRJ7x @UHN
As Chair of the Program Committee for the 1st UHN Postdoc Symposium last year, I know how much effort goes into these events. Great job to the current team on the 2nd! Highly recommend all UHN postdocs join to get inspired and connect. Register now!
🚨 Two-week countdown to our 2nd Annual UHN Postdoc Symposium!
🗓️September 18, 2024
📍Room 2-014, Toronto Rehab Institute
Join us to meet the distinguished panelists and explore success beyond a PhD.
Free for UHN postdocs, students, PIs, and staff!
In vivo CRISPR screen of Epigenetic regulators identity therapeutic targets that rely on tumor microenvironment - our recent work is out at Nature Genetics https://t.co/ccRdwdkS8R
Great teamwork @SoundTsao@DanielSchramek@decarvalho_lab@brooks_lab@kuraoncology and many others
Targeting epigenetic disruptions in cancer holds promise. Our latest paper in @LeukemiaJnl reveals a novel viral mimicry-interferon mechanism enhancing HDAC3 inhibition in GNAS knockout lymphoma. Proud to lead this challenging project with an amazing team!
https://t.co/aIhVPK2DWy
How does mimicking a viral infection in cancer cells boost epigenetic therapy and anti-tumor immunity? 🧬
Check out our latest blog on targeting HDAC3 in lymphoma! 💡
👉 Read more https://t.co/H7j4k34W26
#CancerResearch#Epigenetics#Lymphoma#HDAC3#ViralMimicry#Oncology
Targeting epigenetic disruptions in cancer holds promise. Our latest paper in @LeukemiaJnl reveals a novel viral mimicry-interferon mechanism enhancing HDAC3 inhibition in GNAS knockout lymphoma. Proud to lead this challenging project with an amazing team!
https://t.co/aIhVPK2DWy
👏👏 Super kudos to @pmcancercentre @rkridel for this outstanding translational work in follicular #lymphoma.
From 713 tumor tissue samples (eg, E4402, E2408 & GALLIUM), 5 genetic subtypes discovered and a/w clinicopath findings & pt outcomes.
👉👉 SEE: https://t.co/xJ1BrUCSSB